Listed by the USPTO as MCKILLOP, JOHN CHARLES
Tech Center 1600 • Art Units: 1636 1637 1699
This examiner grants 61% of resolved cases
MCKILLOP, JOHN CHARLES is assigned to Tech Center 1600 and art unit 1636. The record covers 57 resolved cases, with an allowance rate of 61.4%. The median time to allowance is 1451 days, indicating a lengthy path for cases that reach allowance. Because the resolved-case base is limited, the figures should be treated as directional rather than conclusive.
The interview lift is 40.4%, linking interviews with a substantial improvement in allowance outcomes. Counsel may place particular value on preparing a focused technical explanation and using the interview to identify workable claim distinctions. The leading companies are THE GENERAL HOSPITAL Corporation, Lonza Ltd., and Research Institute At Nationwide Children's Hospital. The leading firms are Emerson, Thomson & Bennett, LLC, FOLEY HOAG, LLP (General), and Lathrop GPM LLP | Sanofi-Aventis.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17602076 | Enhancement of Melanocyte Migration Using ROCK Inhibitors | Final Rejection | The General Hospital Corporation |
| 18273643 | MATERIALS AND METHODS FOR THE TREATMENT OF LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D) | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy61.4% of resolved applications examined by John Charles Mckillop were allowed (57 resolved cases), compared with 37.1% across Art Unit 1636 over the last five years.
This examiner's interview lift is +40.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by John Charles Mckillop took 1,451 days on average from filing to allowance.
John Charles Mckillop examines applications in Art Unit 1636 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
